Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grant Sellar

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Proteome Research|November 12, 2009
Stoichiometric quantification of Akt phosphorylation using LC-MS/MSAbdelmadjid Atrih, Dan Turnock, Grant Sellar, et al.
Breast Cancer Research and Treatment|August 14, 2012
Characterisation of tumour-infiltrating macrophages: impact on response and survival in patients receiving primary chemotherapy for breast cancerSteven D Heys, Keith N Stewart, Emma J McKenzie, et al.
Scientific Reports|December 12, 2019
Evaluation of the dual mTOR/PI3K inhibitors Gedatolisib (PF-05212384) and PF-04691502 against ovarian cancer xenograft modelsSimon P Langdon, Charlene Kay, In Hwa Um, et al.
Biomarkers in Medicine|May 19, 2010
Opportunities posed by novel patient selection biomarker approaches in oncology drug development: going beyond the cytotoxicsGrant Sellar, John D Alvarez, Frank Loganzo, et al.
Plos One|September 12, 2013
Comparative gene expression profiling identifies common molecular signatures of NF-κB activation in canine and human diffuse large B cell lymphoma (DLBCL)Manikhandan A V Mudaliar, Ross D Haggart, Gino Miele, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Proteome Research|November 12, 2009
Stoichiometric quantification of Akt phosphorylation using LC-MS/MSAbdelmadjid Atrih, Dan Turnock, Grant Sellar, et al.
Breast Cancer Research and Treatment|August 14, 2012
Characterisation of tumour-infiltrating macrophages: impact on response and survival in patients receiving primary chemotherapy for breast cancerSteven D Heys, Keith N Stewart, Emma J McKenzie, et al.
Scientific Reports|December 12, 2019
Evaluation of the dual mTOR/PI3K inhibitors Gedatolisib (PF-05212384) and PF-04691502 against ovarian cancer xenograft modelsSimon P Langdon, Charlene Kay, In Hwa Um, et al.
Biomarkers in Medicine|May 19, 2010
Opportunities posed by novel patient selection biomarker approaches in oncology drug development: going beyond the cytotoxicsGrant Sellar, John D Alvarez, Frank Loganzo, et al.
Plos One|September 12, 2013
Comparative gene expression profiling identifies common molecular signatures of NF-κB activation in canine and human diffuse large B cell lymphoma (DLBCL)Manikhandan A V Mudaliar, Ross D Haggart, Gino Miele, et al.
Pageof 1